ADENOCARCINOMA OF THE PROSTATE
Clinical trials for ADENOCARCINOMA OF THE PROSTATE explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF THE PROSTATE trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF THE PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a depression drug fight prostate cancer?
Disease control CompletedThis phase 2 trial tested phenelzine sulfate (Nardil), an antidepressant, in 26 men with prostate cancer that returned after initial treatment but hadn't spread. The goal was to see if the drug could lower PSA levels, a marker of cancer activity. Researchers measured how many pat…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New radiation approach shows promise for prostate cancer control
Disease control CompletedThis study tested a new way to give radiation therapy for prostate cancer. It used very precise, high-dose radiation over just five days. The goal was to control the cancer while reducing side effects on the bladder and bowel. 444 men with localized prostate cancer took part, and…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: NA • Sponsor: Fundacao Champalimaud • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New combo therapy for prostate cancer shows promise in early trial
Disease control CompletedThis completed Phase 1/2 trial tested a combination of stereotactic body radiation therapy (5 high-dose sessions) and 4 months of hormone therapy in 45 men with intermediate-risk prostate cancer. The goal was to see how well this approach controls cancer and what side effects occ…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy aims to halt returning prostate cancer
Disease control CompletedThis study tested whether adding the drug enzalutamide to standard radiation therapy can better control prostate cancer that has come back after surgery. Eighty-six men with rising PSA levels after prostate removal took part. The goal was to see if the combination could delay can…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New blood test aims to spot prostate cancer cells earlier
Diagnosis CompletedThis study tested a new blood test called EPISPOT to find prostate cancer cells in the blood of 361 men with localized prostate cancer before they received any treatment. The goal was to see if this test could predict remission better than an existing test called CellSearch. The …
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Glow-in-the-Dark antibody could help surgeons spot prostate cancer
Knowledge-focused CompletedThis early-phase trial tested a fluorescent antibody that attaches to prostate cancer cells. Seven men with moderate- to high-risk prostate cancer received the antibody before robotic prostate removal surgery. The goal was to see if the glowing antibody could help surgeons identi…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC